[The impact of COVID-19 in a cohort of patients with systemic sclerosis].
María Del Pilar Cruz-DomínguezSusana Isabel Morales-MontalvoOlga Lidia Vera-LastraBerenice López-ZamoraIrvin Ordoñez-GonzálezGabriela MedinaCinthya Paola López-BurgosDaniel Héctor Montes-CortésLuis Javier Jara-QuezadaPublished in: Revista medica del Instituto Mexicano del Seguro Social (2023)
COVID-19 disease in patients with SSc can be overcome in most cases, even when they are ILD and were using immunosuppressants at the time of infection with the SARS-CoV-2 virus.